Switch to:

Key Ratios

New Key Statistics Module, Z-Score and F-Score
Market Cap $M556Revenue (TTM) $M28.2Net Margin (%)-584.8Altman Z-Score-6.3
Enterprise Value $M549EPS (TTM) $-1.6Operating Margin %-404.9Piotroski F-Score3
P/E(ttm)--Beneish M-Score65.0Pre-tax Margin (%)-584.5Higher ROA y-yN
Price/Book25.310-y EBITDA Growth Rate %--Quick Ratio7.4Cash flow > EarningsY
Price/Sales19.55-y EBITDA Growth Rate %29.5Current Ratio8.8Lower Leverage y-yN
Price/Free Cash Flow--y-y EBITDA Growth Rate %--ROA % (ttm)-80.7Higher Current Ratio y-yY
Dividend Yield %--PEG--ROE % (ttm)-243.3Less Shares Outstanding y-yN
Payout Ratio %--Shares Outstanding M106ROIC % (ttm)-2,239.1Gross Margin Increase y-yN

Gurus Latest Trades with KERX

Number of guru portfolios checked: 68.
Ticker Guru Date Action
Impact Price Range
Current Price Change from Average Comment Current Shares

KERX is held by these investors:

KERX: Insider Buys/Sells

Click Here for All Insider Trades.
InsiderPosition Date Trades Shares Trade Price ($) Change (%) Details
Madison GregPresident and CEO 2017-02-09Sell1,611$5.47-7.68view
Adams BrianGeneral Counsel and Secretary 2017-01-30Sell6,984$4.658.6view
Neylan John F.Chief Medical Officer 2017-01-30Sell6,984$4.658.6view
Holmes Scott ACFO 2017-01-30Sell8,447$4.658.6view
Madison GregPresident and CEO 2017-01-30Sell18,248$4.658.6view
Neylan John F.Chief Medical Officer 2017-01-23Sell1,428$5.39-6.31view
Adams BrianVP and General Counsel 2017-01-17Sell1,265$6.24-19.07view
Adams BrianVP and General Counsel 2017-01-05Sell759$6.16-18.02view
Madison GregPresident and CEO 2017-01-05Sell1,077$6.16-18.02view
Madison GregPresident and CEO 2016-11-09Sell1,559$4.991.2view

Quarterly/Annual Reports about KERX:

News about KERX:

Articles On GuruFocus.com
Seth Klarman Buys 25 Million Shares of Cascadian Therapeutics as Price Declines Jul 12 2016 
Klarman Gives Insight on Keryx Biopharmaceuticals Investment Jan 26 2016 
Seth Klarman Blames Market, Investments for Rare Down Year Jan 25 2016 
David Abrams Buys Stake in Heavy Equipment Company Dec 15 2015 
Why Seth Klarman Keeps Buying Keryx Biopharma Nov 03 2015 
Seth Klarman Raises Position in Keryx Biopharmaceuticals Oct 21 2015 
Seth Klarman Buys Pharmaceutical Company's Shares to Fund Drug Launch Oct 12 2015 
Is Seth Klarman right about Keryx Inc.? Jun 25 2015 
Seth Klarman Buys Pioneer Natural Resources, SunEdison Semiconductor Ltd, Atara Biotherapeutics Inc, May 15 2015 
Analysts Positive on Keryx Biopharmaceuticals, Inc. Despite Weak Prescription Data May 05 2015 

More From Other Websites
Arena Pharmaceuticals (ARNA) Q4 Earnings: What to Expect? Feb 27 2017
Keryx (KERX) Q4 Earnings: What's in Store for the Stock? Feb 24 2017
Keryx Biopharmaceuticals to Webcast its Presentations at Two Investor Conferences in March 2017 Feb 23 2017
Keryx Biopharmaceuticals to Host Conference Call of Fourth Quarter and Full Year 2016 Financial... Feb 16 2017
Keryx Biopharmaceuticals to Webcast its Presentation at RBC Capital Markets' 2017 Global Healthcare... Feb 08 2017
Drug Approvals Expected to Rise as Trump Pledges to Speed Up Approval Process: Latest Reports on... Feb 01 2017
Keryx Biopharmaceuticals, Inc. – Value Analysis (NASDAQ:KERX) : January 23, 2017 Jan 23 2017
Keryx Biopharmaceuticals, Inc. breached its 50 day moving average in a Bearish Manner : KERX-US :... Jan 20 2017
Keryx Releases Auryxia Data for Iron Deficiency Anemia Jan 13 2017
Keryx Biopharmaceuticals Announces Publication of Auryxia® (ferric citrate) Phase 3 Trial Results... Jan 12 2017
Keryx Biopharma upgraded by Citigroup Jan 11 2017
KERYX BIOPHARMACEUTICALS INC Files SEC form 8-K, Results of Operations and Financial Condition,... Jan 09 2017
Keryx Biopharmaceuticals Announces Recent Business Progress and Reviews Corporate Strategy at 35th... Jan 08 2017
Robbins Arroyo LLP: Keryx Biopharmaceuticals, Inc. (KERX) Misled Shareholders According to a... Jan 05 2017
ETFs with exposure to Keryx Biopharmaceuticals, Inc. : January 3, 2017 Jan 03 2017
Implied Volatility Surging for Keryx (KERX) Stock Options Dec 30 2016
Keryx Biopharmaceuticals to Webcast its Presentation at J.P. Morgan’s 35th Annual Healthcare... Dec 22 2016
ETFs with exposure to Keryx Biopharmaceuticals, Inc. : December 19, 2016 Dec 19 2016

Add Notes, Comments

If you want to ask a question or report a bug, please create a support ticket.
Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)